Referenzen
Produkte Transfektion
Kostenlose Testsamples
Anwendungshinweise:
Im „Transfection Reagent Selection Guide“ können Sie durch Filterfunktionen z.B. für Ihre Kombination aus zu transfizierender Zelle und Nukleinsäure die Liste vorhandener Referenzen durchsuchen. Ebenso können Sie im Feld „Referenzen durchsuchen“ am Anfang der Seite mit passenden Schlagwörtern zu einem Ergebnis gelangen. Eine Referenz zeigt an, dass das gefundene Transfektionsreagenz bereits erfolgreich für die entsprechende Anwendung verwendet wurde. Im Idealfall sind getestete Transfektionsparameter und Transfektionseffizienzen angegeben.
Keine Referenz? > Allgemeine Auswahlhilfe
Wenn Sie keine Referenz gefunden haben, heißt das nicht, dass kein passendes Reagenz zur Verfügung steht, sondern lediglich, dass bisher keine Erfahrungsberichte vorliegen. In diesem Falle kann durch eine Vorauswahl ein erfolgsversprechendes Transfektionsreagenz ausgewählt (Allgemeine Auswahlhilfe) und letztendlich ausgetestet (Kostenlose Testsamples) werden. Wenn Sie einen Erfahrungsbericht für uns schreiben möchten machen wir Ihnen ein Angebot für eine Gegenleistung.
CELL TYPE | DESCRIPTION OF CELL TYPE | CAT.NO. | SPECIES | ORIGIN OF CELLS | COMMON CELL TYPE | GROWTH PROPERTIES | NUCLEIC ACID / DELIVERED MOLECULE | APPLICATION | PRODUCT | REFERENCE TYPE | BIBLIOGRAPHIC DATA | LINK | |
---|---|---|---|---|---|---|---|---|---|---|---|---|---|
U2OS |
Human bone osteosarcoma cell line | ATCC HTB-96 | Human | bone | cell line | adherent | plasmid | Metafectene | publication | M. Lang-Muritano et al., J. of Clinical Endocrinology & Metabolism, 2018, 103(10): 3748–3756 | |||
U2OS |
Human bone osteosarcoma cell line | ATCC HTB-96 | Human | bone | cell line | adherent | plasmid | Metafectene | publication | T. I. Sheikh et al., Translat. Psychiatry, 2021,1 1:1, doi.org/10.1038/s41398-020-01158-w | Link | ||
U251 |
Human brain glioblastoma cell line | Human | brain | cell line | adherent | plasmid | RNA-Interference | Metafectene | publication | R. X. Xu et al., Nan Fang Yi Ke Da Xue Xue Bao, Apr 2006; 26(4): 398-401 | |||
U251 |
Human brain glioblastoma cell line | Human | brain | cell line | adherent | plasmid | stable transfection | Metafectene | publication | C. Hagemann et al., Neuro Oncology, Dec 2013; 15: 1696 - 1709 | Link | ||
U138 MG |
Human brain glioblastoma cell line | ATCC HTB-16 | Human | brain | cell line | adherent | plasmid | stable transfection | Metafectene | publication | C. Hagemann et al., Neuro Oncology, Dec 2013; 15: 1696 - 1709 | Link | |
U-2 OS |
Human bone osteosarcoma cell line | ATCC HTB-96 | Human | bone | cell line | adherent | plasmid | RNA-Interference | Metafectene | publication | L. Zheng et al., Nucleic Acids Res., May 2009; 37: 2645 - 2657 | Link | |
U-2 OS |
Human bone osteosarcoma cell line | ATCC HTB-96 | Human | bone | cell line | adherent | plasmid | Metafectene | publication | T. Dietschy et al., J. Cell Sci., Apr 2009; 122: 1258 - 1267 | Link | ||
TT |
Human medullary thyroid carcinoma cell line | ATCC CRL-1803 | Human | other | cell line | adherent | plasmid | Metafectene | publication | T. Takahashi et al., J. Biochem., Nov 2009; 146: 675 - 682 | |||
tsa201 |
Human embryonic kidney cell line | Human | urinary system | cell line | adherent | plasmid | cotransfection (plasmid/plasmid) | Metafectene | publication | S. Geisler et al., J. of Neuroscience, 2019, 39(14): 2581–2605, 2581, doi.org/10.1523/JNEUROSCI.2234-18.2019 | Link | ||
tsA201 |
Human embryonic kidney cell line | Human | urinary system | cell line | adherent | plasmid | Metafectene | application note | ![]() |
||||
tsa201 |
Human embryonic kidney cell line | Human | urinary system | cell line | adherent | plasmid | virusproduction | Metafectene | publication | S. Geisler et al., J. of Neuroscience, 2019, 39(14): 2581–2605, 2581, doi.org/10.1523/JNEUROSCI.2234-18.2019 | Link | ||
THP-1 |
Human monocytic carcinoma cell line | ATCC TIB 202 | Human | immune system | cell line | suspension | plasmid | RNA-Interference | Metafectene | publication | M.-H. Chien et al., Carcinogenesis, Dec 2009; 30: 2005 - 2013 | ||
THP-1 |
Human monocytic carcinoma cell line | ATCC TIB 202 | Human | immune system | cell line | suspension | oligonucleotide | Metafectene | publication | L. Zheng et al., J. Leukoc. Biol., Sep 2007; 82: 619 - 629 | Link | ||
THP-1 |
Human monocytic carcinoma cell line | ATCC TIB 202 | Human | immune system | cell line | suspension | siRNA | RNA-Interference | Metafectene | publication | S.-K. Kim et al., Cellular & Molecular Immunology, 2017, 14: 349-359 | Link | |
THP-1 |
Human monocytic carcinoma cell line | ATCC TIB 202 | Human | immune system | cell line | suspension | plasmid | Metafectene | application note | ![]() |
|||
THP-1 |
Human monocytic carcinoma cell line | ATCC TIB 202 | Human | immune system | cell line | suspension | siRNA | RNA-Interference | Metafectene | publication | S. Diaz-Moralli et al., Oncotarget, 2016, 7 (32): 51876-51897 | Link | |
THP-1 |
Human monocytic carcinoma cell line | ATCC TIB 202 | Human | immune system | cell line | suspension | plasmid | Metafectene | publication | N. Mukhamedova et al., J. Lipid Res., Nov 2008; 49: 2312 - 2322 | Link | ||
T98G |
Human brain glioblastoma cell line | ATCC CRL-1690 | Human | brain | cell line | adherent | plasmid | Metafectene | publication | D. Guardavaccaro, Dissertation, 2012, Universita degli Studi della Tuscia | Link | ||
T98G |
Human brain glioblastoma cell line | ATCC CRL-1690 | Human | brain | cell line | adherent | siRNA | RNA-Interference | Metafectene | publication | M. Alagoz et al., Nucleic Acids Res., Mar 2014; 42: 3089 - 3103 | Link | |
T98G |
Human brain glioblastoma cell line | ATCC CRL-1690 | Human | brain | cell line | adherent | plasmid | Metafectene | publication | Z. Ping et al., Cell Cycle, 2012, 11: 10, 1999-2005, doi.org/10.4161/cc.20402 | Link | ||
T98G |
Human brain glioblastoma cell line | ATCC CRL-1690 | Human | brain | cell line | adherent | siRNA | RNA-Interference | Metafectene | publication | D. Guardavaccaro, Dissertation, 2012, Universita degli Studi della Tuscia | Link | |
T-REx-293 |
Human embryonic kidney cell line, stably expressing tetracycline repressor (derivat of HEK293) | Human | urinary system | cell line | adherent | plasmid | Metafectene | publication | N. Keinan et al., Mol. Cell. Biol., Dec 2010; 30: 5698 - 5709 | Link | |||
T-REx-293 |
Human embryonic kidney cell line, stably expressing tetracycline repressor (derivat of HEK293) | Human | urinary system | cell line | adherent | plasmid | Metafectene | publication | S.-B. Varda et al., 2012, EP 2 371 846 | Link | |||
T-REx-293 |
Human embryonic kidney cell line, stably expressing tetracycline repressor (derivat of HEK293) | Human | urinary system | cell line | adherent | plasmid | Metafectene | publication | V. Shoshan-Barmatz et al., 2014, US 8,648,045 (Patent) | Link | |||
T-REx-293 |
Human embryonic kidney cell line, stably expressing tetracycline repressor (derivat of HEK293) | Human | urinary system | cell line | adherent | plasmid | RNA-Interference | Metafectene | publication | S. Abu-Hamad et al., J. Biol. Chem., May 2008; 283: 13482 - 13490 | Link |